Indications and Outcomes of Uterine Artery Embolization in Patients with Uterine Leiomyomas

Objective. To investigate the indication and limitations of uterine artery embolization (UAE), we retrospectively analyzed the case of patients with uterine leiomyomas who had undergone UAE. Methods. During the past 7 years, 25 patients with uterine leiomyomas had undergone UAE in our hospital. UAE...

Full description

Saved in:
Bibliographic Details
Main Authors: Hidenori Sasa (Author), Tatsumi Kaji (Author), Kenichi Furuya (Author)
Format: Book
Published: Hindawi Limited, 2012-01-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000 am a22000003u 4500
001 doaj_a23c5ff9c03744e3b240a54cafaab67a
042 |a dc 
100 1 0 |a Hidenori Sasa  |e author 
700 1 0 |a Tatsumi Kaji  |e author 
700 1 0 |a Kenichi Furuya  |e author 
245 0 0 |a Indications and Outcomes of Uterine Artery Embolization in Patients with Uterine Leiomyomas 
260 |b Hindawi Limited,   |c 2012-01-01T00:00:00Z. 
500 |a 1687-9589 
500 |a 1687-9597 
500 |a 10.1155/2012/920831 
520 |a Objective. To investigate the indication and limitations of uterine artery embolization (UAE), we retrospectively analyzed the case of patients with uterine leiomyomas who had undergone UAE. Methods. During the past 7 years, 25 patients with uterine leiomyomas had undergone UAE in our hospital. UAE was indicated in patients with menstrual disturbances such as hypermenorrhea or dysmenorrhea. The outcomes of this procedure for uterine leiomyomas were analyzed. Results. Improvement in the menstrual symptoms and/or reduction in the leiomyoma size after UAE were observed in 24 patients (96.0%). There was mean 67.9% reduction in the volume of leiomyomas at six months after UAE (<0.05). However, the symptoms recurred after UAE in 6 patients (24.0%), with multiple or intramural leiomyomas larger than 7 cm, which necessitated additional procedures. Conclusion. The indications and limitations of the UAE should be considered because of its noneffectiveness and/or recurrence in over 20% of patients with uterine leiomyomas. 
546 |a EN 
690 |a Gynecology and obstetrics 
690 |a RG1-991 
655 7 |a article  |2 local 
786 0 |n Obstetrics and Gynecology International, Vol 2012 (2012) 
787 0 |n http://dx.doi.org/10.1155/2012/920831 
787 0 |n https://doaj.org/toc/1687-9589 
787 0 |n https://doaj.org/toc/1687-9597 
856 4 1 |u https://doaj.org/article/a23c5ff9c03744e3b240a54cafaab67a  |z Connect to this object online.